Skip To Main Content
Retinal Disorders on Muck Rack

Retinal Disorders

As seen in: Nature, Frontiers in Immunology, PR Newswire, EIN News, MENAFN, openPR, EIN Presswire, PR Newswire UK, Wallstreet Online, FinanzNachrichten.de and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Retinal

Contact Retinal, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Case Report: Histamine-mediated inflammation and mast cell modulation in central serous chorioretinopathy: a two case illustrations

|
By Retinal Disorders, Kamali Zonouzi, Babaei Zadeh
| Frontiers in Immunology
Abstract Introduction: Central serous chorioretinopathy (CSCR) is characterized by retinal pigment epithelium dysfunction and choroidal hyperpermeability. Beyond established associations such as psychosocial stress and corticosteroid exposure, experimental and epidemiological findings raise the possibility that mast cell and histamine-related pathways may contribute to CSCR pathophysiology.
Open in Who Shared Issue with article?

Vietnam Ophthalmic Drugs Market By Size, Share and Forecast 2030F

|
By TechSci Research, Retinal Disorders
| techsciresearch.com
Forecast Period 2026-2030 Market Size (2024) USD 478.32 Million Market Size (2030) USD 824.18 Million CAGR (2025-2030) 9.45% Fastest Growing Segment Anti-glaucoma Largest Market Southern Vietnam Market Overview Vietnam Ophthalmic Drugs Market was valued at USD 478.32 Million in 2024 and is expected to reach USD 824.18 Million by 2030 with a CAGR of 9.45% during the forecast period. The Vietnam ophthalmic drugs market is driven by several key factors.
Open in Who Shared Issue with article?

CAGR of 5.6% Driving Growth to $58.13 Billion

|
By Retinal Disorders
| EIN Presswire
WILMINGTON, DE, UNITED STATES, November 22, 2024 / EINPresswire.com/ -- Allied Market Research has recently released an extensive research study titled "Global Ophthalmic Drugs Market Outlook and Forecast 2023-2030." This report provides a comprehensive analysis of market risks, highlights lucrative opportunities, and offers valuable insights to support strategic and tactical decision-making from 2023 to 2030.
Open in Who Shared View Duplicates (7) Issue with article?
See all 40 articles